Bélanger, J.-C.; Bandeira Ferreira, F.L.; Welman, M.; Boulahya, R.; Tanguay, J.-F.; Y.F. So, D.; Lordkipanidzé, M.
Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition—Insights for Multi-Center Trials. J. Clin. Med. 2020, 9, 332.
https://doi.org/10.3390/jcm9020332
AMA Style
Bélanger J-C, Bandeira Ferreira FL, Welman M, Boulahya R, Tanguay J-F, Y.F. So D, Lordkipanidzé M.
Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition—Insights for Multi-Center Trials. Journal of Clinical Medicine. 2020; 9(2):332.
https://doi.org/10.3390/jcm9020332
Chicago/Turabian Style
Bélanger, Jean-Christophe, Fabio Luiz Bandeira Ferreira, Mélanie Welman, Rahma Boulahya, Jean-François Tanguay, Derek Y.F. So, and Marie Lordkipanidzé.
2020. "Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition—Insights for Multi-Center Trials" Journal of Clinical Medicine 9, no. 2: 332.
https://doi.org/10.3390/jcm9020332
APA Style
Bélanger, J.-C., Bandeira Ferreira, F. L., Welman, M., Boulahya, R., Tanguay, J.-F., Y.F. So, D., & Lordkipanidzé, M.
(2020). Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition—Insights for Multi-Center Trials. Journal of Clinical Medicine, 9(2), 332.
https://doi.org/10.3390/jcm9020332